drugset / Trial / NCT00308321

Long Term Tapering or Standard Steroids for Nephrotic Syndrome

NCT00308321

Phase 4 Unknown 50 enrolled Institute of Child Health
RandomizedParallel-groupDouble-blindTreatment

Summary

Parallel group double blind randomised in patients with first episode corticosteroid sensitive nephrotic syndrome comparing time to relapse and adverse effects associated with a longer tapering steroid regimen with standard regime

Timeline

Start
2003-09
Primary completion
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 10 mg/m2
Subject Prednisolone Other / unclassified 40 mg/m2

Indications